Shoji Kudoh
- Pulmonary and Respiratory Medicine top 0.2%
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis 84
- Lung Cancer Treatments and Mutations 38
- Chronic Obstructive Pulmonary Disease (COPD) Research 29
- Respiratory and Cough-Related Research 15
- Physiology top 1%
- Oncology top 2%
- Lung Cancer Research Studies 19
-
- Air Quality and Health Impacts 18
- Cancer Research top 2%
-
- Tuberculosis Research and Epidemiology 19
-
- Mycobacterium research and diagnosis 19
- Co-authors
- Arata AzumaAkihiko GemmaNaoto KeichoMasahiro SeikeMoritaka SugaMasayuki AndoHajime TakizawaToshihiro Nukiwa
- Journals
- Proceedings of the National Academy of Sciences (1 paper)Journal of Clinical Oncology (2 papers)The Journal of Immunology (1 paper)
- Partner nations
- JapanUnited StatesUnited Kingdom
In The Last Decade
Shoji Kudoh
250 papers receiving 9.2k citations
Hit Papers
Peers
Comparison fields: 5 of 160
- Pulmonary and Respiratory Medicine 5.2k
- Physiology 1.6k
- Oncology 1.5k
- Health, Toxicology and Mutagenesis 719
- Cancer Research 757
Countries citing papers authored by Shoji Kudoh
This map shows the geographic impact of Shoji Kudoh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shoji Kudoh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shoji Kudoh more than expected).
Fields of papers citing papers by Shoji Kudoh
This network shows the impact of papers produced by Shoji Kudoh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shoji Kudoh. The network helps show where Shoji Kudoh may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Shoji Kudoh, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 3 | |
| 2 | 2022 | 4 | |
| 3 | 2020 | 23 | |
| 4 | 2014 | 141 | |
| 5 | 2013 | 4 | |
| 6 | Historical changes in epidemiology of diffuse panbronchiolitis. | 2012 | 7 |
| 7 | 2009 | 67 | |
| 8 | 2008 | 81 | |
| 9 | 2008 | 365 | |
| 10 | 2007 | 49 | |
| 11 | Double-blind, Placebo-controlled Trial of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosisbreakdown → | 2005 | 681 |
| 12 | 2005 | 51 | |
| 13 | 2004 | 14 | |
| 14 | 2004 | 8 | |
| 15 | 2000 | 116 | |
| 16 | 2000 | 3 | |
| 17 | 1999 | 3 | |
| 18 | Improvement of Survival in Patients with Diffuse Panbronchiolitis Treated with Low-dose Erythromycinbreakdown → | 1998 | 444 |
| 19 | 1998 | 40 | |
| 20 | 1995 | 36 |
About Shoji Kudoh
Shoji Kudoh is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Speech and Hearing, having authored 258 papers that have together received 9.5k indexed citations. Recurring topics across this work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (84 papers), Lung Cancer Treatments and Mutations (38 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (29 papers), Tuberculosis Research and Epidemiology (19 papers), Mycobacterium research and diagnosis (19 papers), Lung Cancer Research Studies (19 papers), Air Quality and Health Impacts (18 papers) and Respiratory and Cough-Related Research (15 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (5.2k citations), Physiology (1.6k citations) and Oncology (1.5k citations). Shoji Kudoh has collaborated with scholars based in Japan, United States and United Kingdom. Frequent co-authors include Arata Azuma, Akihiko Gemma, Naoto Keicho, Masahiro Seike, Moritaka Suga, Masayuki Ando, Hajime Takizawa, Toshihiro Nukiwa, Yoshio Taguchi and Koichiro Nakata. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and The Journal of Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.